#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	5658	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2649	631.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1692	1692	C	781	C,G	720,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8654	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4041	641.3	0	.	n	.	0	T695C	SNP	695	695	T	1267	1267	C	648	C,T,G,A	570,1,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8654	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4041	641.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1909	1909	A	745	A	685	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8654	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4041	641.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2543	2543	C	788	C,G,A	725,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8654	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4041	641.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2617	2617	A	852	A	777	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8654	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4041	641.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3169	3169	C	761	C,T	669,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	838	folP	852	852	100.0	folP.l15.c4.ctg.1	2133	117.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1429	1431	AGC	166;166;168	A,G;G;C	153,1;155;151	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1564	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3926	119.4	1	SNP	p	S91F	0	.	.	271	273	TCC	850	852	TCC	135;135;134	T,G;C;C	121,1;119;125	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1564	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3926	119.4	1	SNP	p	D95N	0	.	.	283	285	GAC	862	864	GAC	132;131;131	G;A;C	123;121;123	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1564	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3926	119.4	1	SNP	p	D95G	0	.	.	283	285	GAC	862	864	GAC	132;131;131	G;A;C	123;121;123	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	M16I	NONSYN	46	48	ATG	642	644	ATT	121;121;122	A;T;T	108;109;109	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	R44H	NONSYN	130	132	CGC	726	728	CAC	114;114;114	C;A;C	107;107;107	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	I73M	NONSYN	217	219	ATC	813	815	ATG	91;91;91	A;T;G	86;84;85	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	A74S	NONSYN	220	222	GCG	816	818	TCG	91;91;91	T,G;C;G	83,2;86;83	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	Q75K	NONSYN	223	225	CAA	819	821	AAA	91;92;92	A,C;A;A	83,1;86;85	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	A77T	NONSYN	229	231	GCC	825	827	ACG	93;93;93	A;C;G	85;85;87	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	E78_D79insN	INS	232	232	G	828	828	G	93	G	87	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	D79N	NONSYN	235	237	GAT	834	836	AAT	93;93;93	A;A;T,C	87;86;83,1	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	G83Q	NONSYN	247	249	GGG	846	848	CAA	94;94;94	C,G;A,G;A	88,1;88,1;87	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	H90R	NONSYN	268	270	CAC	867	869	CGT	97;97;97	C;G,T,A;T,C	91;88,1,1;88,1	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	912	914	CAC	97;95;94	C;A;C	86;85;87	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	N110S	NONSYN	328	330	AAC	927	929	AGC	90;89;88	A;G,A;C	77;76,1;78	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	V143F	NONSYN	427	429	GTT	1026	1028	TTT	55;54;54	T,G;T;T	46,3;49;46	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	A154S	NONSYN	460	462	GCT	1059	1061	TCG	47;46;46	T;C;G	44;42;44	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	D155G	NONSYN	463	465	GAC	1062	1064	GGT	45;44;43	G;G;T	42;39;41	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	T161M	NONSYN	481	483	ACG	1080	1082	ATG	41;41;41	A;T;G	39;40;38	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	T169M	NONSYN	505	507	ACC	1104	1106	ATG	39;39;39	A;T;G	34;37;38	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	F178L	NONSYN	532	534	TTC	1131	1133	CTC	37;37;37	C;T;C	35;37;35	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	C181G	NONSYN	541	543	TGC	1140	1142	GGT	38;37;37	G;G;T	35;34;35	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	R183N	NONSYN	547	549	CGT	1146	1148	AAT	35;35;35	A;A;T	34;35;33	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	G195E	NONSYN	583	585	GGG	1182	1184	GAA	33;33;33	G;A,G;A	32;31,1;31	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	0	.	p	.	0	D206Q	NONSYN	616	618	GAC	1215	1217	CAG	25;26;26	C,T;A,G;G,A,C	23,1;25,1;23,1,1	.	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	539	284	mtrR	633	633	91.19	mtrR.l6.c4.ctg.1	1516	56.0	1	SNP	p	G45D	0	.	.	133	135	GGC	729	731	GGC	113;113;113	G,C;G;C	106,1;108;103	mtrR.Neisseria_meningitidis_H44_76_v1_00513:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1770	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	152.7	1	SNP	p	D86N	0	.	.	256	258	GAC	844	846	GAC	200;200;200	G,A,T;A;C	176,1,1;175;182	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1770	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	152.7	1	SNP	p	S87R	0	.	.	259	261	AGT	847	849	AGT	197;198;197	A,C,G;G;T,C	170,2,1;180;176,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1770	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	152.7	1	SNP	p	S87W	0	.	.	259	261	AGT	847	849	AGT	197;198;197	A,C,G;G;T,C	170,2,1;180;176,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1770	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	152.7	1	SNP	p	S87I	0	.	.	259	261	AGT	847	849	AGT	197;198;197	A,C,G;G;T,C	170,2,1;180;176,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1770	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3474	152.7	1	SNP	p	S88P	0	.	.	262	264	TCC	850	852	TCC	196;197;198	T;C;C	173;179;180	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1500	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3292	136.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1922	1924	GGC	182;181;181	G,A;G,T;C	167,1;160,1;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1635	1637	GCA	192;191;192	G,C;C;A	177,1;174;179	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1638	1640	ATC	191;190;192	A;T;C	175;164;175	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1650	1652	GTG	195;195;195	G;T,G;G,T	178;176,1;171,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1650	1652	GTG	195;195;195	G;T,G;G,T	178;176,1;171,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2154	2156	ACC	149;149;149	A;C;C	132;132;135	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2208	2210	GCG	148;148;149	G;C;G,A	132;119;123,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2208	2210	GCG	148;148;149	G;C;G,A	132;119;123,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2331	2333	GGC	132;132;132	G,C;G,C;C	118,1;122,1;118	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2340	2342	GGC	135;135;134	G;G;C	121;121;117	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1288	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	128.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2358	2360	CCG	139;139;139	C,G,A;C;G,A	121,1,1;127;123,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1890	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3532	160.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1835	1837	CTG	179;180;179	C,A;T;G,C	154,1;155;156,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	918	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2316	118.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	821	821	C	131	C,T	116,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	144	porB1a	984	293	90.91	porB1a.l15.c30.ctg.1	1257	30.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	989	991	AAT	19;19;19	A;A;T	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	144	porB1a	984	293	90.91	porB1a.l15.c30.ctg.1	1257	30.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	992	994	AAT	19;18;18	A;A;T	15;16;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	144	porB1a	984	293	90.91	porB1a.l15.c30.ctg.1	1257	30.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1016	1018	GCA	15;15;15	G;C;A	15;13;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	144	porB1a	984	293	90.91	porB1a.l15.c30.ctg.1	1257	30.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1039	1041	GTA	14;14;14	G;T;A	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	144	porB1a	984	293	90.91	porB1a.l15.c30.ctg.1	1257	30.2	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1048	1048	A	15	A	15	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	714	716	GTT	242;241;239	G;T;T	223;219;216	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	0	.	p	.	0	I75V	NONSYN	223	225	ATT	804	806	GTT	247;247;247	G;T,G;T	233;226,1;231	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	0	.	p	.	0	S89T	NONSYN	265	267	AGC	846	848	ACC	254;255;255	A,C;C;C	234,1;239;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	0	.	p	.	0	I98V	NONSYN	292	294	ATC	873	875	GTC	260;258;258	G;T,G;C	236;234,1;236	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	0	.	p	.	0	S217N	NONSYN	649	651	AGT	1230	1232	AAT	233;232;232	A;A,C,G,T;T,G	210;210,1,1,1;207,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	1	SNP	p	G120K	1	.	.	358	360	AAG	939	941	AAG	257;256;256	A,C;A;G	226,1;221;221	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	1	SNP	p	N121D	0	.	.	361	363	AAC	942	944	AAC	255;255;255	A,G;A;C	218,1;221;227	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1090	porB1b	1038	1038	99.42	porB1b.l15.c4.ctg.1	1940	164.7	1	SNP	p	A121N	1	.	.	361	363	AAC	942	944	AAC	255;255;255	A,G;A;C	218,1;221;227	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3368	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	5329	189.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2264	2266	AAT	206;206;207	A;A;T	190;183;190	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	506	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1765	86.0	1	SNP	p	V57M	1	.	.	169	171	ATG	858	860	ATG	166;167;169	A;T;G	155;159;157	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
